ZARR — RXRX

THU 05 NOV
06:50 Investing.com - UK Form 4 Recursion Pharmaceuticals Inc: Blake Borgeson (Director) For: 3 November 2 items · also Investing.com - UK
06:46 Investing.com - UK Recursion Pharmaceuticals director Blake Borgeson sells $155,200 in stock
00:12 [DATA] GuruFocus Director Blake Borgeson Sells 40,000 Shares of Recursion Pharmaceuticals Inc (RXRX)
WED 04 NOV
TUE 03 NOV CLOSE 3.68 -3.9% VOL 0.7×
15:59 [DATA] GuruFocus Recursion Pharmaceuticals (RXRX) Faces Elevated Short Interest Amid Polarized Healthcare Sentiment
05:01 [DATA] GuruFocus RXRX SWOT Analysis: Financial Challenges and Strategic Collaborations Revealed in 10-Q Filing 2 items
MON 02 NOV CLOSE 3.83 -5.0% VOL 0.7×
23:26 [DATA] GuruFocus Recursion (RXRX) Reports Promising Phase 2 TUPELO Trial Results for REC-4881 in Familial ...
23:26 [DATA] GuruFocus Recursion Pharmaceuticals (RXRX) Surpasses Q3 Revenue Estimates, Highlighting AI-Driven Drug ... 3 items · also GuruFocus, SEC EDGAR - 8-K atom
12:32 [DATA] GuruFocus Earnings To Watch: Recursion Pharmaceuticals Inc (RXRX) Q3 2026 -- GF Value Sees 33% Downside
FRI 30 OCT CLOSE 4.03 -5.0% VOL 0.8×
THU 29 OCT CLOSE 4.24 -2.5% VOL 0.7×
WED 28 OCT CLOSE 4.35 +7.4% VOL 0.9×
TUE 27 OCT CLOSE 4.05 +6.6% VOL 0.7×
MON 26 OCT CLOSE 3.80 +2.7% VOL 0.5×
FRI 23 OCT CLOSE 3.70 +3.4% VOL 0.6×
THU 22 OCT CLOSE 3.58 -1.6% VOL 0.6×
WED 21 OCT CLOSE 3.64 -0.5% VOL 0.6×
TUE 20 OCT CLOSE 3.66 +1.4% VOL 0.7×
MON 19 OCT CLOSE 3.61 +4.2% VOL 0.9×
FRI 16 OCT CLOSE 3.46 -16.7% VOL 1.3×
THU 15 OCT CLOSE 4.16 +11.2% VOL 2.0×
WED 14 OCT CLOSE 3.74 -2.5% VOL 0.6×
TUE 13 OCT CLOSE 3.84 -4.4% VOL 0.7×
MON 12 OCT CLOSE 4.01 -8.0% VOL 0.8×
FRI 09 OCT CLOSE 4.36 +10.4% VOL 1.2×
THU 08 OCT CLOSE 3.95 -7.5% VOL 1.1×
WED 07 OCT CLOSE 4.27 -7.8% VOL 1.6×
TUE 06 OCT CLOSE 4.63 -3.1% VOL 3.0×
MON 05 OCT CLOSE 4.78 +16.0% VOL 3.1×
FRI 02 OCT CLOSE 4.12 +1.2% VOL 0.9×
THU 01 OCT CLOSE 4.07 -1.5% VOL 0.8×
WED 30 SEPT CLOSE 4.13 +2.5% VOL 1.7×
TUE 29 SEPT CLOSE 4.03 +8.9% VOL 1.1×
MON 28 SEPT CLOSE 3.70 -1.1% VOL 0.7×
FRI 25 SEPT CLOSE 3.74 -3.9% VOL 0.5×